Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
Recruiting · NCT06607588 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
View the official record on ClinicalTrials.gov →Interventions studied
Not applicable- observational study
What this trial is about
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients able to understand and sign the informed consent form.
- Documented HIV-1 infection.
- Under the first line TLD for at least 6 months.
- At least 3 months follow-up with CV \>200c/ml.
Exclusion criteria
- Patients \<18 years of age.
- Under the first line regime other than TLD.
- Patients with active neoplastic processes.
- Patients with active opportunistic diseases.
- Patients unable to give informed consent.
Where it is running
1 location listed.
- Hospital Carmelo - Chokwé, Mozambique